GlucoTrack Inc (GCTK) Stock Analysis

GlucoTrack Inc (GCTK) is a publicly traded company in the HEALTHCARE sector. It trades at $0.66, carries a market capitalization of $4.26M, a price-to-earnings ratio of 0.11. This page summarizes the public market data, fundamentals, and frequently asked questions for GCTK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $0.66
• Market Cap: $4.26M
• P/E Ratio: 0.11
• EPS: $6.27
• 52-Week High: $14.14
• 52-Week Low: $0.43

Market Sentiment

GlucoTrack Inc currently has a Bullish sentiment score of 0.43.

About GlucoTrack Inc

GlucoTrack, Inc. is a forward-thinking medical device company based in Or Yehuda, Israel, specializing in the development of innovative non-invasive glucose monitoring solutions designed for individuals with diabetes and prediabetes. The company is strategically focused on enhancing patient care through advanced technology, targeting key markets in Europe and the Asia Pacific. With its dedication to pioneering non-invasive monitoring solutions, GlucoTrack is well-positioned to capitalize on t...

GNG Research Analysis

GNG Research scores GlucoTrack Inc (GCTK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GCTK.

Frequently Asked Questions

Does GCTK pay dividends?

GlucoTrack Inc (GCTK) does not currently pay a regular dividend.

What is GCTK's P/E ratio?

GlucoTrack Inc has a price-to-earnings (P/E) ratio of 0.11.

What is GCTK's market cap?

GlucoTrack Inc (GCTK) has a market capitalization of $4.26M with a current stock price of $0.66.